𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alternative medicine use in patients with localized prostate carcinoma treated with curative intent

✍ Scribed by Marguerite C. Lippert; Rebecca McClain; James C. Boyd; Dan Theodorescu

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
123 KB
Volume
86
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

Alternative medicine therapies are estimated to be used by 7-64% of cancer patients but up to 72% do not inform their physician. To the authors' knowledge little useful information is available regarding the prevalence of alternative medicine use by patients with prostate carcinoma. Thus, the authors attempted to evaluate the prevalence of alternative medicine use by prostate carcinoma patients treated with curative intent by either radical prostatectomy, brachytherapy alone, or a combination of brachytherapy and external radiation therapy.

πŸ“œ SIMILAR VOLUMES

DNA ploidy and survival of patients with
DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cure
✍ Borre, Michael; HΓΈyer, Morten; NerstrΓΈm, Benni; Overgaard, Jens πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 163 KB πŸ‘ 2 views

BACKGROUND. The optimal approach to diagnosis and treatment of localized prostate cancer remains controversial. Deoxyribonucleic acid (DNA) ploidy has been suggested as an important predictor for outcome in prostate cancer. The purpose of this study was to correlate DNA ploidy with disease-specific

Use of quality indicators to evaluate th
Use of quality indicators to evaluate the care of patients with localized prostate carcinoma
✍ David C. Miller; Mark S. Litwin; Martin G. Sanda; James E. Montie; Rodney L. Dun πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 1 views

## Background: The goal of quality assurance in health care is to preserve and improve patient care. recently, rand developed a set of evidence-based candidate indicators for evaluating the quality of care for patients with localized prostate carcinoma; however, the feasibility and sensitivity of t